---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-210399"
form_type: "8-K"
ticker: null
cik: "0001851194"
company_name: "Ventyx Biosciences, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:51:18.155313+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ventyx CFO Martin D. Auster departs; Roy Gonzales appointed interim CFO/PAO

## Summary
- Appointed Roy M. Gonzales as interim principal financial officer and interim principal accounting officer effective Aug 30, 2024, replacing Martin D. Auster.
- Dr. Auster's separation agreement provides nine months base salary continuation, COBRA reimbursement, and accelerated vesting of equity vesting within three months.
- Gonzales joined as SVP of Finance in April 2024; previously VP of Accounting; salary $350k, 30% target bonus.
- No changes to Gonzales' compensation or terms from his interim appointment.
- No family relationships or material transactions with Gonzales requiring disclosure.

## SEC filing metadata
- accession: 0001193125-24-210399
- form_type: 8-K
- cik: 0001851194
- company_name: Ventyx Biosciences, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/0001193125-24-210399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/d884852d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-210399
- JSON: https://secwatch.observer/filing/0001193125-24-210399.json
- Plain text: https://secwatch.observer/filing/0001193125-24-210399.txt

## Key facts
- Executive change
  Roy M. Gonzales was appointed as interim principal financial officer and interim principal accounting officer at Ventyx Biosciences, Inc..
  - Action: appointed
  - Role: interim principal financial officer and interim principal accounting officer
  source text: appointed Roy M. Gonzales, the Company’s Senior Vice President of Finance, as the Company’s interim principal financial officer and interim principal accounting officer, effective as of August 30, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/0001193125-24-210399-index.htm
- Executive change
  Martin D. Auster resigned as Chief Financial Officer at Ventyx Biosciences, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Dr. Auster ceased employment as the Company’s Chief Financial Officer, effective as of August 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1851194/000119312524210399/0001193125-24-210399-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.